Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market.
Lithium has been used for over half a century for the treatment of bipolar disorder as the archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in this role. Despite this, the specific mechanisms by which lithium exerts its mood-stabilizing effects are not well understood.
Lithium can be used off-label to treat: 1  Agitation that is not associated with bipolar disorder. 2  Depression. 3  Graves' disease (a form of hyperthyroidism)  Migraine headaches or cluster 1  headaches. Neutropenia (low levels of neutrophils, a type of white blood cells) that is caused by chemotherapy or other medications.